Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
| Author | |
|---|---|
| Abstract | :
Dyslipidaemia is common in perinatally HIV-infected (PHIV) youth receiving protease inhibitors (PIs). Few studies have evaluated longitudinal lipid changes in PHIV youth after switch to newer PIs. |
| Year of Publication | :
2018
|
| Journal | :
HIV medicine
|
| Volume | :
19
|
| Issue | :
3
|
| Number of Pages | :
175-183
|
| ISSN Number | :
1464-2662
|
| URL | :
https://doi.org/10.1111/hiv.12566
|
| DOI | :
10.1111/hiv.12566
|
| Short Title | :
HIV Med
|
| Download citation |